Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study is to evaluate the safety and efficacy of RAL-based regimen in treatment-experienced patients with resistant HIV infection
Epistemonikos ID: 0683db1b7d724d9e9971a48247831edb4e16493a
First added on: May 11, 2024